<DOC>
	<DOCNO>NCT01673594</DOCNO>
	<brief_summary>The purpose study ) ass efficacy naltrexone prevent stimulant-induced euphoria adult ADHD , b ) ass whether naltrexone interfere clinical efficacy stimulant treat adult ADHD , c ) ass whether naltrexone interfere effect stimulant neurotransmitter activity . We predict naltrexone successfully prevent stimulant-induced euphoria without interfere ability stimulant effectively treat ADHD adult . This study 8 -week trial young adult ( 18-24 ) ADHD .</brief_summary>
	<brief_title>Prevention Stimulant-Induced Euphoria With Opioid Receptor Antagonist</brief_title>
	<detailed_description />
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Narcotic Antagonists</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Inclusion 1 . Male female outpatient 2. age 1830 3. diagnosis ADHD DSMIV , per clinical evaluation confirm structure interview 4. likeability response ( &gt; 5 ) Question # 2 DRQS initial test dose 60 mg IR MPH . 5 . Baseline ADHD severity &gt; 20 Adult ADHD Investigator System Report Scale ( AISRS ) 6 . Able participate blood draw swallow pill . 7 . Subjects must consider reliable reporter , must understand nature study must sign informed consent document Exclusion 1 . Any current ( last month ) , nonADHD Axis I psychiatric condition 2 . HamD &gt; 16 , BDI &gt; 19 , HamA &gt; 21 3 . Any clinically significant chronic medical condition 4. cardiovascular disease hypertension 5 . Clinically significant abnormal baseline laboratory value 6 . I.Q . &lt; 80 ) 7 . Organic brain disorder 8 . Seizures tics 9 . Pregnant nursing female 10 . Clinically unstable psychiatric condition ( i.e . suicidal behavior , psychosis ) 11 . Current recent ( within past year ) substance abuse/dependence 12. patient psychotropics 13 . Current prior adequate treatment MPH 14. know hypersensitivity methylphenidate 15 . Current opioid use ( history urine screen ) potential need opioid analgesic study 16. acute hepatitis liver failure ( baseline blood test ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>SODAS MPH</keyword>
	<keyword>Stimulant-Induced Euphoria</keyword>
	<keyword>Substance Abuse</keyword>
	<keyword>Adults</keyword>
</DOC>